Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms

Psychiatry Research

Volumn 150, Issue 1, 2007, Pages 61-69

  Ma, Ning ^a   Tan, Li wen ^a   Wang, Qiang ^b   Li, Ze xuan ^a   Li, Ling jiang ^a  

^a Central South University   (China)

^b ZHEJIANG HOSPITAL   (China)

Author keywords

Clinical characteristic; Clozapine; Obsessive compulsive disorder; Obsessive compulsive symptoms; Schizophrenia; Serotonin

Indexed keywords

CLOZAPINE; SEROTONIN;

ADULT; ARTICLE; CLINICAL FEATURE; COMPULSION; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; HAMILTON ANXIETY SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; OBSESSIVE COMPULSIVE DISORDER; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEROTONIN BLOOD LEVEL; SEROTONIN METABOLISM; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEROTONIN; STATISTICS;

EID: 33847153920     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2005.10.005     Document Type: Article

References (66)

1. Ackenheil M., Blatt B., and Lampart C. Effect of clozapine on 5-HIAA excretion in urine and CSF of psychotic patients and on serotonin metabolism in rat brain. Acta Vitaminologica et Enzymologica 29 (1975) 79-84
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), APA, Washington, DC
3. Attiullah N., Eisen J.L., and Rasmussen S.A. Clinical features of obsessive-compulsive disorder. Psychiatric Clinics of North America 23 (2000) 469-491
4. Aymard N., Viala A., Baldacci C., Smagghe P.O., Vacheron M.N., and Caroli F. Pharmacoclinical strategy in neuroleptic resistant schizophrenic patients treated by clozapine: clinical evolution, concentration of plasma and red blood cell clozapine and desmethylclozapine, whole blood serotonin and tryptophan. Progress in Neuro-psychopharmacology & Biological Psychiatry 23 (1999) 25-41
5. Baker R.W., Chengappa K.N., Baird J.W., Steingard S., Christ M.A., and Schooler N.R. Emergence of obsessive compulsive symptoms during treatment with clozapine. Journal of Clinical Psychiatry 53 (1992) 439-442
6. Banki C.M. 5-Hydroxytryptamine content of the whole blood in psychiatric illness and alcoholism. Acta Psychiatica Scandinavica 57 (1978) 232-238
7. Banki C.M. Alterations of cerebrospinal fluid 5-hydroxyindoleacetic acid, and total blood serotonin content during clozapine treatment. Psychopharmacology (Berlin) 56 (1978) 195-198
8. Benkelfat C., Murphy D.L., Zohar J., Hill J.L., Grover G., and Insel T.R. Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action. Archives of General Psychiatry 46 (1989) 23-28
9. Bermanzohn P.C., Porto L., Arlow P.B., Pollack S., Stronger R., and Siris S.G. Hierarchical diagnosis in chronic schizophrenia: a clinical study of co-occurring syndromes. Schizophrenia Bulletin 26 (2000) 517-525
10. Borcsiczky D., Tekes K., Tarcali J., Meszaros Z., Faludi G., Mathe M., and Magyar K. Platelet rich plasma serotonin content in patients suffering from different psychiatric disorders. Acta Physiologica Hungarica 84 (1996) 403-404
11. Braunig P., Rao M.L., and Fimmers R. Blood serotonin levels in suicidal schizophrenic patients. Acta Psychiatrica Scandinavica 79 (1989) 186-189
12. Breier A. Serotonin, schizophrenia and antipsychotic drug action. Schizophrenia Research 14 (1995) 187-202
13. Byerly M., Goodman W., Acholonu W., Bugno R., and Rush A.J. Obsessive compulsive symptoms in schizophrenia: frequency and clinical features. Schizophrenia Research 76 (2005) 309-316
14. Camarena B., Aguilar A., Loyzaga C., and Nicolini H. A family-based association study of the 5-HT-1Dbeta receptor gene in obsessive-compulsive disorder. International Journal of Neuropsychopharmacology 7 (2004) 49-53
15. Cath D.C., Spinhoven P., Landman A.D., and van Kempen G.M. Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder. Journal of Psychopharmacology 15 (2001) 111-119
16. Chabane N., Millet B., Delorme R., Lichtermann D., Mathieu F., Laplanche J.L., Roy I., Mouren M.C., Hankard R., Maier W., Launay J.M., and Leboyer M. Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive-compulsive disorder by case control and family association study in humans. Neuroscience Letters 363 (2004) 154-156
17. Chen J., Xiao Z.-p., Lin Z.-g., and Wang K.-x. Platelet serotonin, plasma prolactin and dexa methasone suppression test in patients with obseeive compulsive disorder. Chinese Journal of Psychiatry 37 (2004) 14-17
18. de Haan L., Linszen D.H., and Gorsira R. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. Journal of Clinical Psychiatry 60 (1999) 364-365
19. DeLisi L.E., Neckers L.M., Weinberger D.R., and Wyatt R.J. Increased whole blood serotonin concentrations in chronic schizophrenic patients. Archives of General Psychiatry 38 (1981) 647-650
20. Delorme R., Chabane N., Callebert J., Falissard B., Mouren-Simeoni M.C., Rouillon F., Launay J.M., and Leboyer M. Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder. Journal of Clinical Psychopharmacology 24 (2004) 18-23
21. 1Dbeta receptor gene. American Journal of Psychiatry 159 (2002) 1783-1785
22. Dursun S.M., Szemis A., Andrews H., Whitaker P., and Reveley M.A. Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study. Journal of Psychiatry and Neuroscience 25 (2000) 347-352
23. Eales M.J., and Layeni A.O. Exacerbation of obsessive-compulsive symptoms associated with clozapine. British Journal of Psychiatry 164 (1994) 687-688
24. Fabisch K., Fabisch H., Langs G., Huber H.P., and Zapotoczky H.G. Incidence of obsessive-compulsive phenomena in the course of acute schizophrenia and schizoaffective disorder. European Journal of Psychiatry 16 (2001) 336-341
25. Flament M.F., Rapoport J.L., Murphy D.L., Berg C.J., and Lake C.R. Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder. Archives of General Psychiatry 44 (1987) 219-225
26. Galvez-Buccollini J.A., Fiestas F., Herrera P., Vega-Dienstmaier J.M., Guimas B., and Mazzotti G. Obsessive-compulsive symptoms in schizophrenia during treatment with clozapine and conventional antipsychotic drugs. Actas Españolas de Psiquiatría 32 (2004) 211-215
27. Garelis E., Gillin J.C., Wyatt R.J., and Neff N. Elevated blood serotonin concentrations in unmedicated chronic schizophrenic patients: a preliminary study. American Journal of Psychiatry 132 (1975) 184-186
28. Goodman W., Price H., Rasmussen S., and Blake J.B. The Yale Brown Obsessive Compulsive Scale (Y-BOCS): Part I. Development, use, and reliability. Archives of General Psychiatry 46 (1989) 1006-1011
29. Greist J., Chouinard G., DuBoff E., Halaris A., Kim S.W., Koran L., Liebowitz M., Lydiard R.B., Rasmussen S., and White K. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Archives of General Psychiatry 52 (1995) 289-295
30. Hanna G.L., Yuwiler A., and Cantwell D.P. Whole blood serotonin in juvenile obsessive-compulsive disorder. Biological Psychiatry 29 (1991) 738-744
31. Insel T.R., Mueller E.A., Alterman I., Linnoila M., and Murphy D.L. Obsessive-compulsive disorder and serotonin: is there a connection?. Biological Psychiatry 20 (1985) 1174-1188
32. Jackman H., Luchins D., and Meltzer H.Y. Platelet serotonin levels in schizophrenia: relationship to race and psychopathology. Biological Psychiatry 18 (1983) 887-902
33. Jakovljevic M., Muck-Seler D., Pivac N., Ljubicic D., Bujas M., and Dodig G. Seasonal influence on platelet 5-HT levels in patients with recurrent major depression and schizophrenia. Biological Psychiatry 41 (1997) 1028-1034
34. Joseph M.H., Owen F., Baker H.F., and Bourne R.C. Platelet serotonin concentration and monoamine oxidase activity in unmedicated chronic schizophrenic and in schizoaffective patients. Psychological Medicine 7 (1977) 159-162
35. Katz R.J., DeVeaugh-Geiss J., and Landau P. Clomipramine in obsessive-compulsive disorder. Biological Psychiatry 28 (1990) 401-414
36. Kolakowska T., and Molyneux S.G. Platelet serotonin concentration in schizophrenic patients. American Journal of Psychiatry 144 (1987) 232-234
37. LaPorta L.D. More on obsessive-compulsive symptoms and clozapine. Journal of Clinical Psychiatry 55 (1994) 312
38. Lesch K.P., Wolozin B.L., Murphy D.L., and Riederer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. Journal of Neurochemistry 60 (1993) 2319-2322
39. Lucey J.V., Butcher G., Clare A.W., and Dinan T.G. Buspirone induced prolactin responses in obsessive-compulsive disorder (OCD): is OCD a 5-HT2 receptor disorder?. International Clinical Psychopharmacology 7 (1992) 45-49
40. MacCabe J.H., and Travis M. Clozapine-induced obsessive-compulsive symptoms. Progress in Neuro-psychopharmacology & Biological Psychiatry 28 (2004) 1209
41. Markianos M., Botsis A., and Arvanitis Y. Biogenic amine metabolites in plasma of drug-naive schizophrenic patients: associations with symptomatology. Biological Psychiatry 32 (1992) 288-292
42. Markianos M., Hatzimanolis J., Lykouras L., and Christodoulou G.N. Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine. Schizophrenia Research 56 (2002) 11-17
43. Muck-Seler D., Jakovljevic M., and Deanovic Z. Time course of schizophrenia and platelet 5-HT level. Biological Psychiatry 23 (1988) 243-251
44. Muck-Seler D., Jakovljevic M., and Deanovic Z. Platelet serotonin in subtypes of schizophrenia and unipolar depression. Psychiatry Research 38 (1991) 105-113
45. Muck-Seler D., Bujas M., Ljubic-Thibal V., and Jakovljevic M. Effect of age on platelet 5-HT concentrations in healthy controls, depressed and schizophrenic patients. Neuropsychobiology 34 (1996) 201-203
46. Muck-Seler D., Pivac N., and Jakovljevic M. Sex differences, season of birth and platelet 5-HT levels in schizophrenic patients. Journal of Neural Transmission 106 (1999) 337-347
47. Muck-Seler D., Pivac N., Jakovljevic M., and Brzovic Z. Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients. Biological Psychiatry 45 (1999) 1433-1439
48. Muck-Seler D., Pivac N., Mustapic M., Crncevic Z., Jakovljevic M., and Sagud M. Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women. Psychiatry Research 127 (2004) 217-226
49. Oades R.D., Ropcke B., and Eggers C. Monoamine activity reflected in urine of young patients with obsessive compulsive disorder, psychosis with and without reality distortion and healthy subjects: an explorative analysis. Journal of Neural Transmission. General Section 96 (1994) 143-159
50. Oades R.D., Klimke A., Henning U., and Rao M.L. Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia. Human Psychopharmacology 17 (2002) 15-27
51. Oades R.D., Roepcke B., Henning U., and Klimke A. Neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity. Behavioral and Brain Functions 1 (2005) 14
52. Ongur D., and Goff D.C. Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status. Schizophrenia Research 75 (2005) 349-362
53. Piccinelli M., Pini S., Bellantuono C., and Wilkinson G. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review. British Journal of Psychiatry 166 (1995) 424-443
54. Poyurovsky M., Fuchs C., and Weizman A. Obsessive-compulsive disorder in patients with first-episode schizophrenia. American Journal of Psychiatry 156 (1999) 1998-2000
55. Poyurovsky M., Hramenkov S., Isakov V., Rauchverger B., Modai I., Schneidman M., Fuchs C., and Weizman A. Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia. Psychiatry Research 102 (2001) 49-57
56. Poyurovsky M., Kriss V., Weisman G., Faragian S., Kurs R., Schneidman M., Fuchs C., Weizman A., and Weizman R. Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia. Journal of Clinical Psychiatry 64 (2003) 1300-1307
57. Rabe-Jablonska J. Obsessive-compulsive disorders in adolescents with diagnosed schizophrenia. Psychiatria Polska 35 (2001) 47-57
58. Ravizza L., Barzega G., Bellino S., Bogetto F., and Maina G. Drug treatment of obsessive-compulsive disorder (OCD): long-term trial with clomipramine and selective serotonin reuptake inhibitors (SSRIs). Psychopharmacology Bulletin 32 (1996) 167-173
59. Reznik I., Yavin I., Stryjer R., Spivak B., Gonen N., Strous R., Mester R., Weizman A., and Kotler M. Clozapine in the treatment of obsessive-compulsive symptoms in schizophrenia patients: a case series study. Pharmacopsychiatry 37 (2004) 52-56
60. Scheepers F.E., Gespen de Wied C.C., and Kahn R.S. The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia. Journal of Clinical Psychopharmacology 21 (2001) 575-582
61. Schulz E., Fleischhaker C., and Remschmidt H.E. Correlated changes in symptoms and neurotransmitter indices during maintenance treatment with clozapine or conventional neuroleptics in adolescents and young adults with schizophrenia. Journal of Child and Adolescent Psychopharmacology 6 (1996) 119-131
62. Schulz E., Fleischhaker C., Clement H.W., and Remschmidt H. Blood biogenic amines during clozapine treatment of early-onset schizophrenia. Journal of Neural Transmission 104 (1997) 1077-1089
63. Stahl S.M., Woo D.J., Mefford I.N., Berger P.A., and Ciaranello R.D. Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders. American Journal of Psychiatry 140 (1983) 26-30
64. Xiao R., Beck O., and Hjemdahl P. On the accurate measurement of serotonin in whole blood. Scandinavian Journal of Clinical & Laboratory Investigation 58 (1998) 505-510
65. Xiao Z.-p., Zhang M.-d., Wang Z., and Chen Y. A comparative study of platelet serotonin in patients with obsessive-compulsive disorder. Chinical Journal of Psychiatry 36 (2003) 211-214
66. Zohar J., and Insel T.R. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biological Psychiatry 22 (1987) 667-687